bupropion has been researched along with s,n,n'-tripropylthiocarbamate in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (38.71) | 29.6817 |
| 2010's | 15 (48.39) | 24.3611 |
| 2020's | 4 (12.90) | 2.80 |
| Authors | Studies |
|---|---|
| Bruijnzeel, AW; Cryan, JF; Markou, A; Skjei, KL | 1 |
| Bruijnzeel, AW; Markou, A | 1 |
| Berrettini, W; Crystal-Mansour, S; Epstein, LH; Leonard, DG; Lerman, C; Patterson, F; Pinto, A; Restine, SL; Shields, PG; Wileyto, EP | 1 |
| Gonsai, K; Gonzalez, G; Kosten, TR; Martell, B; Oliveto, A; Petry, N; Poling, J; Sofuoglu, M | 1 |
| Jasmin, L; Narasaiah, M; Tien, D | 1 |
| Balfour, DJ; Markou, A; Paterson, NE | 2 |
| Cherng, CF; Lin, YC; Su, SW; Yu, L | 1 |
| Bardo, MT; Crooks, PA; Dwoskin, LP; Joyce, BM; Neugebauer, NM; Pivavarchyk, M; Zhang, Z; Zheng, G | 1 |
| Rose, JE | 1 |
| Alcantara, LF; Bolaños-Guzmán, CA; Iñiguez, SD; Maffeo, ML; Manojlovic, Z; Parise, EM; Schuh, B; Warren, BL | 1 |
| Even-Sapir, E; Greif, J; Lerman, H; Weinstein, A; Weizman, A; Yemini, Z | 1 |
| Caggiula, AR; Donny, EC; Levin, ME; Mays, KL; Palmatier, MI; Sved, AF | 1 |
| Blough, BE; Carroll, FI; Damaj, MI; Grabus, SD; King, LS; Lukas, RJ; Navarro, HA; Vann, RE; Warner, JA; Wiley, JL | 1 |
| Glaser, PE; Hays, LR; Lile, JA; Rush, CR; Stoops, WW | 1 |
| Capello, E; Krueger, F; Mancardi, G; Pardini, M; Uccelli, A | 1 |
| Altet Gómez, N; Barrueco Ferrero, M; de Granda Orive, JI; Jiménez-Ruiz, CA; Lorza Blasco, JJ; Martinez Muñiz, MA; Ramos Pinedo, A; Riesco Miranda, JA; Signes-Costa Miñana, J; Solano Reina, S | 1 |
| Hokazono, M; Mori, T; Ogawa, Y; Rahmadi, M; Shibasaki, M; Suzuki, T; Wang, TC | 1 |
| Blough, B; Carroll, FI; Damaj, MI; Malcolm, E; Shoaib, M | 1 |
| Abler, B; Graf, H; Metzger, CD; Walter, M | 1 |
| Dean, Z; Giannopoulos, P; Horndasch, S; McCabe, C | 1 |
| Barrett, ST; Bevins, RA; Geary, TN; Steiner, AN | 1 |
| Cinciripini, PM; Engelmann, JM; Green, CE; Karam-Hage, M; Minnix, JA; Robinson, JD; Versace, F; Wetter, DW | 1 |
| Fischer, W; Gelderblom, H; Hoffmann, R; Landwehrmeyer, B; McLean, T; Mütze, L; Priller, J; Saft, C; Schlattmann, P; Süssmuth, S; van Duijn, E; Wüstenberg, T | 1 |
| Browning, M; Drevets, WC; Furey, M; Harmer, CJ; Walsh, AEL | 1 |
| Daniels, S; Flynn, A; Horman, T; Hudson, R; Leri, F; Levy, A; Zhou, Y | 1 |
| Fukayama, H; Funayama, T; Ikeda, Y; Okubo, Y; Suzuki, H; Tateno, A | 1 |
| Adams, P; Almeida, J; Ang, YS; Bruder, G; Carmody, T; Chase, HW; Chin Fatt, CR; Cooper, CM; Deckersbach, T; Deldin, P; Fava, M; Kaiser, R; McGrath, P; McInnis, MG; Oquendo, MA; Parsey, R; Phillips, ML; Pizzagalli, DA; Trivedi, MH; Webb, CA; Weissman, M | 1 |
| Ayoub, S; Horman, T; Leri, F | 1 |
| Chin Fatt, C; Cooper, C; Fava, M; Jha, MK; Kurian, B; McGrath, PJ; Mellema, C; Montillo, AA; Nguyen, KP; Phillips, ML; Treacher, A; Trivedi, MH; Weissman, M | 1 |
| Holden, JM | 1 |
1 review(s) available for bupropion and s,n,n'-tripropylthiocarbamate
| Article | Year |
|---|---|
New findings on nicotine addiction and treatment.
Topics: Animals; Benzazepines; Bupropion; Humans; Mecamylamine; Motivation; Nicotine; Nicotinic Antagonists; Quinoxalines; Reward; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline | 2009 |
11 trial(s) available for bupropion and s,n,n'-tripropylthiocarbamate
| Article | Year |
|---|---|
Changes in food reward following smoking cessation: a pharmacogenetic investigation.
Topics: Adult; Bupropion; Case-Control Studies; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Food; Humans; Male; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Receptors, Dopamine D2; Reward; Smoking; Smoking Cessation; Treatment Outcome; White People | 2004 |
Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population.
Topics: Adult; Behavior Therapy; Bupropion; Cocaine; Cocaine-Related Disorders; Combined Modality Therapy; Comorbidity; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Heroin Dependence; Humans; Male; Methadone; Placebos; Psychiatric Status Rating Scales; Reward; Substance Abuse Detection | 2006 |
Attenuation of cue-induced smoking urges and brain reward activity in smokers treated successfully with bupropion.
Topics: Adult; Affect; Aged; Brain; Brain Mapping; Bupropion; Cues; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Psychotherapy, Group; Radionuclide Imaging; Reward; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome | 2010 |
Influence of acute bupropion pre-treatment on the effects of intranasal cocaine.
Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Bupropion; Choice Behavior; Cocaine; Cocaine-Related Disorders; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Humans; Male; Reward | 2012 |
Serotonergic antidepressants decrease hedonic signals but leave learning signals in the nucleus accumbens unaffected.
Topics: Adult; Antidepressive Agents, Second-Generation; Brain Mapping; Bupropion; Cross-Over Studies; Dopamine Uptake Inhibitors; Double-Blind Method; Erotica; Functional Laterality; Humans; Learning; Magnetic Resonance Imaging; Male; Motion Perception; Neuropsychological Tests; Nucleus Accumbens; Paroxetine; Reward; Selective Serotonin Reuptake Inhibitors; Sexual Behavior | 2016 |
Enhanced neural response to anticipation, effort and consummation of reward and aversion during bupropion treatment.
Topics: Adult; Anticipation, Psychological; Bupropion; Cerebrum; Cross-Over Studies; Dopamine Uptake Inhibitors; Double-Blind Method; Feeding Behavior; Female; Humans; Magnetic Resonance Imaging; Male; Reward; Taste Perception; Young Adult | 2016 |
Benefits of varenicline vs. bupropion for smoking cessation: a Bayesian analysis of the interaction of reward sensitivity and treatment.
Topics: Adult; Antidepressive Agents, Second-Generation; Bayes Theorem; Bupropion; Follow-Up Studies; Humans; Middle Aged; Nicotinic Agonists; Reward; Smoking Cessation; Tobacco Smoking; Treatment Outcome; Varenicline | 2017 |
Bupropion for the treatment of apathy in Huntington's disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Apathy; Brain; Bupropion; Cross-Over Studies; Double-Blind Method; Female; Functional Neuroimaging; Humans; Huntington Disease; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Reward; Treatment Outcome | 2017 |
Bupropion increases activation in nucleus accumbens during anticipation of monetary reward.
Topics: Adult; Anticipation, Psychological; Bupropion; Cross-Over Studies; Dopamine Uptake Inhibitors; Female; Humans; Magnetic Resonance Imaging; Male; Motivation; Norepinephrine; Nucleus Accumbens; Photic Stimulation; Reward; Single-Blind Method | 2019 |
Pretreatment Reward Sensitivity and Frontostriatal Resting-State Functional Connectivity Are Associated With Response to Bupropion After Sertraline Nonresponse.
Topics: Adult; Bupropion; Depressive Disorder, Major; Humans; Prospective Studies; Reward; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2020 |
Patterns of Pretreatment Reward Task Brain Activation Predict Individual Antidepressant Response: Key Results From the EMBARC Randomized Clinical Trial.
Topics: Antidepressive Agents; Biomarkers; Brain; Bupropion; Calcium Phosphates; Depressive Disorder, Major; Humans; Reward; Sertraline; Treatment Outcome | 2022 |
19 other study(ies) available for bupropion and s,n,n'-tripropylthiocarbamate
| Article | Year |
|---|---|
Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain; Bupropion; Drug Administration Schedule; Electric Stimulation; Male; Nicotine; Rats; Rats, Wistar; Receptors, Nicotinic; Reward; Substance Withdrawal Syndrome | 2003 |
Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats.
Topics: Animals; Bupropion; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Down-Regulation; Eating; Feeding Behavior; Male; Nicotine; Rats; Rats, Wistar; Reinforcement, Psychology; Reward; Self Administration; Tobacco Use Disorder | 2003 |
Noradrenaline is necessary for the hedonic properties of addictive drugs.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Appetitive Behavior; Benzazepines; Biphenyl Compounds; Bupropion; Carbidopa; Cocaine; Dopamine beta-Hydroxylase; Dopamine Uptake Inhibitors; Droxidopa; Female; Genotype; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Morphine; Naltrexone; Narcotic Antagonists; Neurokinin-1 Receptor Antagonists; Norepinephrine; Receptors, Adrenergic, alpha-1; Receptors, Dopamine D1; Reward; Substance-Related Disorders | 2006 |
Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell.
Topics: Animals; Bupropion; Dopamine; Dopamine Uptake Inhibitors; Drug Administration Schedule; Male; Nucleus Accumbens; Potassium; Rats; Rats, Wistar; Reward; Substance Withdrawal Syndrome; Synaptic Transmission; Tobacco Use Disorder; Up-Regulation | 2007 |
Prenatal exposure of bupropion may enhance agitation, anxiety responses, and sensitivity to cocaine effects in adult mice.
Topics: Aging; Animals; Antidepressive Agents, Second-Generation; Anxiety; Bupropion; Cocaine; Dose-Response Relationship, Drug; Female; Mice; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Agitation; Reward | 2007 |
Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain; Bupropion; Conditioning, Psychological; Drug Administration Schedule; Electric Stimulation; Male; Nicotine; Rats; Rats, Wistar; Receptors, Nicotinic; Reward; Substance Withdrawal Syndrome | 2008 |
Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzazepines; Brain; Bupropion; Dopamine; Dose-Response Relationship, Drug; Drugs, Investigational; Male; Neurons; Nicotine; Nicotinic Antagonists; Picolines; Quaternary Ammonium Compounds; Quinoxalines; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Receptors, Nicotinic; Reward; Smoking Cessation; Structure-Activity Relationship; Tobacco Use Disorder; Varenicline; Ventral Tegmental Area | 2009 |
Nicotine exposure during adolescence induces a depression-like state in adulthood.
Topics: Aging; Animals; Antidepressive Agents, Second-Generation; Anxiety; Bupropion; Cholinergic Agents; Depression; Emotions; Fluoxetine; Food Preferences; Male; Motor Activity; Nicotine; Rats; Rats, Sprague-Dawley; Reward; Stress, Psychological; Weight Gain | 2009 |
Bupropion and nicotine enhance responding for nondrug reinforcers via dissociable pharmacological mechanisms in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Bupropion; Conditioning, Operant; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Mecamylamine; Motivation; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Prazosin; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Reward; Time Factors | 2009 |
Effects of hydroxymetabolites of bupropion on nicotine dependence behavior in mice.
Topics: Animals; Anxiety; Behavior, Animal; Bupropion; Conditioning, Operant; Discrimination Learning; Discrimination, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Emotions; Hydroxylation; Hyperalgesia; Mice; Mice, Inbred ICR; Nicotine; Nicotinic Agonists; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2010 |
Reward responsiveness and fatigue in multiple sclerosis.
Topics: Adult; Anxiety; Attention; Bupropion; Citalopram; Cognition; Depression; Disability Evaluation; Disorders of Excessive Somnolence; Dopamine Uptake Inhibitors; Fatigue; Female; Humans; Inhibition, Psychological; Male; Multiple Sclerosis; Neuropsychological Tests; Perception; Personality; Reaction Time; Recurrence; Reward; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2013 |
Treatment of smoking in smokers with chronic obstructive pulmonary disease. Sociedad Española de Neumología y Cirugía Torácica (SEPAR).
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Follow-Up Studies; Humans; Motivation; Multicenter Studies as Topic; Program Evaluation; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Randomized Controlled Trials as Topic; Reward; Severity of Illness Index; Smoking; Smoking Cessation; Spain; Surveys and Questionnaires; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2013 |
Comparison of the behavioral effects of bupropion and psychostimulants.
Topics: Animals; Behavior, Animal; Bupropion; Cocaine; Male; Methamphetamine; Mice; Motor Activity; Psychotropic Drugs; Reward; Substance-Related Disorders | 2013 |
Examination of the metabolite hydroxybupropion in the reinforcing and aversive stimulus effects of nicotine in rats.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Bupropion; Male; Nicotine; Rats; Receptors, Nicotinic; Reward; Self Administration; Smoking Cessation; Tobacco Use Disorder | 2015 |
Sex differences and the role of dopamine receptors in the reward-enhancing effects of nicotine and bupropion.
Topics: Animals; Bupropion; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Female; Male; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Reward; Sex Characteristics | 2017 |
Dissociable temporal effects of bupropion on behavioural measures of emotional and reward processing in depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Depression; Emotions; Female; Humans; Male; Reward; Time Factors; Young Adult | 2018 |
Bupropion and naltrexone combination alters high fructose corn syrup self-administration and gene expression in rats.
Topics: Animals; Anti-Obesity Agents; Brain; Bupropion; Drug Combinations; Feeding Behavior; Gene Expression Regulation; High Fructose Corn Syrup; Male; Motor Activity; Naltrexone; Random Allocation; Rats, Sprague-Dawley; Reward; RNA, Messenger; Self Administration | 2018 |
Evidence of hypoglycemic anhedonia and modulation by bupropion in rats.
Topics: Anhedonia; Animals; Antidepressive Agents, Second-Generation; Appetitive Behavior; Bupropion; Deoxyglucose; Depression; High Fructose Corn Syrup; Hypoglycemia; Hypoglycemic Agents; Male; Rats; Rats, Sprague-Dawley; Reward; Self Administration; Taste | 2021 |
Effects of bupropion on sign- and goal-tracking in male Sprague Dawley rats.
Topics: Animals; Bupropion; Cues; Goals; Male; Motivation; Rats; Rats, Sprague-Dawley; Recurrence; Reward | 2023 |